A Win For ContraFect Corporation
ContraFect Corporation (CFRX:NASDAQ) soared at $2.29, representing a gain of 154.4%. On Mon, Apr 17, 2023, CFRX:NASDAQ touched a New 2-Week High of $2.29. The stock appeared on our News Catalysts scanner on Thu, Apr 13, 2023 at 11:43 AM in the 'BIOTECH' category. From Mon, Apr 03, 2023, the stock recorded 11.11% Up Days and 0.00% Green Days
The stock spiked on Mon, Apr 17, 2023 at $3.95 with a volume of 120M+.
About ContraFect Corporation (CFRX:NASDAQ)
ContraFect Corp is a biotechnology company engaged in the development of protein and antibody therapeutic products for life-threatening infectious diseases. The Company's product candidates are CF-301, CF-404.
Top 10 Gainers:
- Presto Automation Inc Com (PRST:NASDAQ), 158.57%
- ContraFect Corporation (CFRX:NASDAQ), 154.44%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 102.85%
- Ignyta, Inc. (RXDX:NASDAQ), 69.73%
- Satsuma Pharmaceuticals, Inc. (STSA:NASDAQ), 63.69%
- Versus Systems Inc. (VS:NASDAQ), 53.58%
- Charah Solutions, Inc. (CHRA:NYSE), 49.32%
- Toro Corp. (TORO:NASDAQ), 45.98%
- Gamida Cell Ltd. (GMDA:NASDAQ), 38.79%
- Charah Solutions Inc. 8.50% Senior Notes due 2026 (CHRB:NYSE), 38.18%